| Stage | PRAA | % of rev | NRDS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $372M | 100.00% | $197M | 100.00% | PRAA ×1.89 |
| Gross profit | $302M | 81.09% | $184M | 93.21% | NRDS +12.1pp |
| Operating income | $153M | 41.19% | $7M | 3.55% | PRAA +37.6pp |
| Pre-tax income | $88M | 23.73% | $7M | 3.70% | PRAA +20.0pp |
| Net income | $59M | 15.84% | $4M | 2.18% | PRAA +13.7pp |
| Stage | PRAA | NRDS | Gap · A − B |
|---|---|---|---|
| Revenue | $372M100.00% | $197M100.00% | PRAA ×1.89 |
| Gross profit | 81.09%$302M | 93.21%$184M | NRDS +12.1pp |
| Operating income | 41.19%$153M | 3.55%$7M | PRAA +37.6pp |
| Pre-tax income | 23.73%$88M | 3.70%$7M | PRAA +20.0pp |
| Net income |
| 15.84%$59M |
| 2.18%$4M |
| PRAA +13.7pp |
No disclosed counterparties: PRAA, NRDS.